Beyond Air Inc Total Liabilities

Latest as of March 2026: $29.18 Million USD

Beyond Air Inc total liabilities. Based on the latest financial reports, Beyond Air Inc (XAIR) has total liabilities worth $29.18 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Beyond Air Inc to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Beyond Air Inc (2014–2026)

Total liabilities of Beyond Air Inc from 2014 to 2026. This chart illustrates how Beyond Air Inc's total liabilities have evolved over time, based on quarterly financial data.

Beyond Air Inc Competitors by Total Liabilities

The table below lists competitors of Beyond Air Inc ranked by their total liabilities.

Company Country Total Liabilities
Masivo Silver Corp
V:MASS
Canada CA$479.21K
Eurocell PLC
LSE:ECEL
UK GBX195.90 Million
QEM Ltd
AU:QEM
Australia AU$566.92K
JINGRUI HLDGS LTD DL-01
F:9JW
Germany €29.93 Billion
TROC DE L'ILE SA
PA:MLTRO
France €2.65 Million
Haoxin Holdings Limited Class A Ordinary Shares
NASDAQ:HXHX
USA $22.65 Million
Golden Sun Education Group Ltd
NASDAQ:GSUN
USA $9.67 Million
TECIL Chemicals and Hydro Power Limited
NSE:TECILCHEM
India Rs230.03 Million

Liability Composition Analysis (2014–2026)

This chart breaks down Beyond Air Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Beyond Air Inc asset portfolio.

Liquidity & Leverage Metrics

Beyond Air Inc Total Liabilities Ratios Explained

Beyond Air Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 3.80 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 4.76 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.82 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Beyond Air Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Beyond Air Inc (2014–2026)

The table below shows the annual total liabilities of Beyond Air Inc from 2014 to 2026.

Year Total Liabilities Change
2026-03-31 $29.18 Million +85.58%
2025-03-31 $15.72 Million -47.20%
2024-03-31 $29.77 Million +11.43%
2023-03-31 $26.72 Million +27.30%
2022-03-31 $20.99 Million +108.61%
2021-03-31 $10.06 Million +7.70%
2020-03-31 $9.34 Million +72.90%
2019-03-31 $5.40 Million -30.82%
2018-03-31 $7.81 Million +25012.07%
2017-03-31 $31.10K 0.00%
2016-03-31 $31.10K -98.03%
2015-03-31 $1.58 Million +271.29%
2014-03-31 $425.00K --

About Beyond Air Inc

NASDAQ:XAIR USA Medical Devices
Market Cap
$1.67 Million
Market Cap Rank
#30226 Global
#6160 in USA
Share Price
$2.32
Change (1 day)
+4.98%
52-Week Range
$0.35 - $8.24
All Time High
$15.61
About

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company. It operates through Beyond Air, Beyond Cancer, and NeuroNos segments. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO to treat viral lung infections, such as viral community-acquired pneumonia, including COVID-19 and b… Read more